![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07H 19/20 | (2006.01) |
C07H 19/14 | (2013.01) | ||
C07H 19/14 | (2006.01) | ||
C07H 19/20 | (2013.01) | ||
C07H 19/207 | (2006.01) | ||
C07H 19/207 | (2013.01) | ||
C07H 19/23 | (2006.01) | ||
C07H 19/23 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 35/02 | (2006.01) | ||
A61P 35/02 | (2018.01) | ||
A61K 31/7076 | (2006.01) | ||
A61K 31/7084 | (2013.01) | ||
C07H 21/04 | (2013.01) | ||
A61K 31/708 | (2006.01) | ||
A61K 31/7084 | (2006.01) | ||
C07H 21/04 | (2006.01) | ||
A61K 31/706 | (2006.01) | ||
A61K 31/7064 | (2006.01) |
(11) | Number of the document | 3658565 |
(13) | Kind of document | T |
(96) | European patent application number | 18752985.4 |
Date of filing the European patent application | 2018-07-26 | |
(97) | Date of publication of the European application | 2020-06-03 |
(45) | Date of publication and mention of the grant of the patent | 2022-11-09 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2018/043907 |
Date | 2018-07-26 |
(87) | Number | WO 2019/023459 |
Date | 2019-01-31 |
(30) | Number | Date | Country code |
201762538329 P | 2017-07-28 | US |
(72) |
FINK, Brian E. , US
DODD, Dharmpal S. , US
QIN, Lan-ying , US
RUAN, Zheming , US
ZHAO, Yufen , US
HARIKRISHNAN, Lalgudi S. , US
KAMAU, Muthoni G. , US
WALKER, Steven J. , US
|
(73) |
Bristol-Myers Squibb Company ,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
(54) | CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS |
CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS |